Minireview: Basal-like breast cancer: from molecular profiles to targeted therapies
about
Claudin 1 in Breast Cancer: New InsightsBreast Cancer: Conventional Diagnosis and Treatment Modalities and Recent Patents and TechnologiesA phenotypic mouse model of basaloid breast tumorsGenomic analysis of the ecdysone steroid signal at metamorphosis onset using ecdysoneless and EcRnull Drosophila melanogaster mutants.Extracts from Curcuma zedoaria Inhibit Proliferation of Human Breast Cancer Cell MDA-MB-231 In Vitro.Transcriptomic classification of genetically engineered mouse models of breast cancer identifies human subtype counterparts.Precision medicine in breast cancer: reality or utopia?Weight Loss Reversed Obesity-Induced HGF/c-Met Pathway and Basal-Like Breast Cancer ProgressionThe three receptor tyrosine kinases c-KIT, VEGFR2 and PDGFRα, closely spaced at 4q12, show increased protein expression in triple-negative breast cancer.αB-crystallin promotes oncogenic transformation and inhibits caspase activation in cells primed for apoptosis by Rb inactivation.Molecular insights on basal-like breast cancer.Pathway-centric integrative analysis identifies RRM2 as a prognostic marker in breast cancer associated with poor survival and tamoxifen resistance.Luminal A and luminal B (HER2 negative) subtypes of breast cancer consist of a mixture of tumors with different genotype.αB-crystallin: a novel regulator of breast cancer metastasis to the brainObesity-mediated regulation of HGF/c-Met is associated with reduced basal-like breast cancer latency in parous mice.MicroRNA-200 family modulation in distinct breast cancer phenotypes.TTK/hMPS1 is an attractive therapeutic target for triple-negative breast cancer.Inhibition of the Warburg effect with a natural compound reveals a novel measurement for determining the metastatic potential of breast cancers.FOXF2 deficiency promotes epithelial-mesenchymal transition and metastasis of basal-like breast cancerClinical trials in the era of personalized oncology.Detection of miRNA regulatory effect on triple negative breast cancer transcriptome.Lectin chromatography/mass spectrometry discovery workflow identifies putative biomarkers of aggressive breast cancers.Regulation of triple-negative breast cancer cell metastasis by the tumor-suppressor liver kinase B1.How interacting pathways are regulated by miRNAs in breast cancer subtypes.MicroRNA-31 sensitizes human breast cells to apoptosis by direct targeting of protein kinase C epsilon (PKCepsilon).Weight loss reduces basal-like breast cancer through kinome reprogrammingp16 expression correlates with basal-like triple-negative breast carcinomaIntegrated analysis of genome-wide DNA methylation and gene expression profiles in molecular subtypes of breast cancerαB-crystallin: Portrait of a malignant chaperone as a cancer therapeutic targetαB-crystallin Expression in Breast Cancer is Associated with Brain Metastasis.Obesity, metabolism and the microenvironment: Links to cancerLapatinib-loaded human serum albumin nanoparticles for the prevention and treatment of triple-negative breast cancer metastasis to the brain.Epigenetic silencing of ARRDC3 expression in basal-like breast cancer cellsRole of HGF in obesity-associated tumorigenesis: C3(1)-TAg mice as a model for human basal-like breast cancer.Molecular Analysis of BRCA1 in Human Breast Cancer Cells Under Oxidative Stress.Tissue proteomics of the human mammary gland: towards an abridged definition of the molecular phenotypes underlying epithelial normalcy.Molecular classification of breast carcinomas with particular emphasis on "basal-like" carcinoma: a critical review.Promotion of breast cancer cells MDA-MB-231 invasion by di(2-ethylhexyl)phthalate through matrix metalloproteinase-2/-9 overexpression.Silencing the roadblocks to effective triple-negative breast cancer treatments by siRNA nanoparticles.Structural analysis of BRCA1 reveals modification hotspot.
P2860
Q26774988-9FA48FBF-F910-440E-9316-A23175B0F40FQ26783705-48C3277C-BBEB-451C-96A6-2117DFF19723Q28480588-5C02E5E5-CF11-4C2F-ACA2-51F42C5D236FQ30536951-40299EF1-D35E-4E34-85DD-F1BDFB3ECD76Q33634352-1EF28942-C477-4372-983E-4A2A9F57D0FDQ33742688-4D721112-C124-442B-A28C-5BF9A8AAF6FAQ33809114-B6FEE140-48DA-4E9A-87CD-C64FF62FC6FAQ33859809-633ABDAF-CE87-4EC9-9F40-AC9143B85CA5Q33903662-AA90A575-50E0-4734-A09A-9D292D966FECQ33932784-B951FAB3-E493-4D04-A5CC-A7AA43FA9529Q34123314-0696575E-FF6C-411D-9C7D-BBE57D78AAD1Q34346725-B763069E-AC83-4306-BF12-929E46389948Q34351294-5E6D1878-3530-469B-AACF-911AFB6FD6A7Q34378205-CC79A7A9-6F25-4CC5-A15C-9EB1893D125CQ34420979-361F8678-0003-4821-918D-912CDF072CE7Q34462262-6EFAD61D-A139-4777-81FE-8AB05FDF44EAQ34735167-C1786B37-4CDD-4BD9-8C87-50E1849F4329Q35176109-6FC5070E-D29A-4768-B678-E048C4A18DA0Q35180874-0ADC2E13-93D8-419E-9B07-9618887B1BEBQ35555963-1051B4A0-006F-4ECE-A3C2-AFE7B771F432Q35653875-10BC9CF4-C688-49E0-9312-E7F0757198F8Q36058024-32FAC4F1-A3AC-476B-841F-F5C34979C1EAQ36245941-5D9A550F-164E-4A9F-BDD7-9BDF66A188ACQ36276533-609469EB-2BB0-463D-BBB3-1498C41E2162Q36708704-853DAFB9-D041-407A-88AF-575F4AF1BD79Q36758643-316F94C7-35B0-4867-8C2A-221DD78E4EAFQ36863171-8CC83AF2-D162-405E-BD1C-AF42B463B9C0Q37224735-A1C01488-D0C5-45BE-BD60-946D5FEC22D1Q37241367-D126CD33-5E69-4795-84C0-C0C2FBD29F41Q37265368-6D363BBD-DB35-4097-8CA4-CB60C0D86341Q37276139-AAD20B9D-40F8-4258-B3E2-23ECAD3F8029Q37376191-78E0D93B-3203-4A92-8476-2166BFADCC18Q37511632-76AD61BE-C060-4F0A-B978-3154592F405CQ37523867-0D11FC8C-B14F-4B0D-91F7-A41A418CCB64Q37682104-2C945DD0-B154-478F-ABA9-A8C67592590CQ37805245-4E06123E-C73D-4458-BCF0-AC8E3E665B7FQ37974614-028FBEB9-E04C-4D20-8357-6304ECE97EE4Q38796179-D41969F9-09BE-4439-B89F-656F509A5EFFQ39113994-87592FE9-D42F-4957-8B53-A5A9AD0586AAQ41694949-51D78CCF-66E3-4CC1-B675-6BD4A66BF9DE
P2860
Minireview: Basal-like breast cancer: from molecular profiles to targeted therapies
description
2010 nî lūn-bûn
@nan
2010 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Minireview: Basal-like breast cancer: from molecular profiles to targeted therapies
@ast
Minireview: Basal-like breast cancer: from molecular profiles to targeted therapies
@en
Minireview: Basal-like breast cancer: from molecular profiles to targeted therapies
@nl
type
label
Minireview: Basal-like breast cancer: from molecular profiles to targeted therapies
@ast
Minireview: Basal-like breast cancer: from molecular profiles to targeted therapies
@en
Minireview: Basal-like breast cancer: from molecular profiles to targeted therapies
@nl
prefLabel
Minireview: Basal-like breast cancer: from molecular profiles to targeted therapies
@ast
Minireview: Basal-like breast cancer: from molecular profiles to targeted therapies
@en
Minireview: Basal-like breast cancer: from molecular profiles to targeted therapies
@nl
P2860
P356
P1476
Minireview: Basal-like breast cancer: from molecular profiles to targeted therapies
@en
P2093
Daniel J Toft
Vincent L Cryns
P2860
P304
P356
10.1210/ME.2010-0164
P577
2010-09-22T00:00:00Z